Companies collaborating on new approach to stem cell-based drug screening – MedCity News
| MedCity News TEL AVIV (Reuters) – Merck Serono and Israel’s Kadimastem signed a memorandum of understanding aimed at advancing their stem cell-based drug screening collaboration initiated in 2012, the companies said on Monday. Kadimastem has developed … Merck Serono and Kadimastem Sign MOU on Drug Screening and Discovery for …Jewish Business News |
